Name: Lyell Immunopharma, Inc. (LYEL) Balance Sheet
Creator: FinSpry

Lyell Immunopharma Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Lyell Immunopharma, Inc. (LYEL) - Annual data in billions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	0.11	0.55	0.12	0.29	0.14
Short-Term Investments	0.26	0.40	0.52	0.32	0.47
Cash & Short-Term Investments	0.37	0.55	0.64	0.61	0.61
Accounts Receivable	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.01	0.00	0.01	0.01	0.00
Total Current Assets	0.38	0.55	0.65	0.63	0.62
Non-Current Assets
Property, Plant & Equipment (Net)	0.07	0.14	0.17	0.17	0.12
Long-Term Investments	0.03	0.05	0.12	0.33	0.16
Other Non-Current Assets	0.01	0.00	0.00	0.00	0.00
Total Non-Current Assets	0.11	0.20	0.29	0.50	0.00
Total Assets	0.49	0.75	0.94	1.13	0.91
Current Liabilities
Accounts Payable	0.01	0.03	0.00	0.00	0.01
Short-Term Debt	0.01	0.00	0.00	0.00	0.00
Accrued Liabilities	0.01	0.02	0.02	0.02	0.02
Deferred Revenue	0.00	0.00	0.00	0.00	0.01
Other Current Liabilities	0.04	0.00	0.01	0.02	0.01
Total Current Liabilities	0.05	0.03	0.04	0.05	0.05
Non-Current Liabilities
Long-Term Debt	0.05	0.06	0.06	0.07	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	0.05	0.06	0.07	0.15	0.00
Total Liabilities	0.11	0.10	0.10	0.20	0.19
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-1.35	-1.00	-0.77	-0.58	-0.33
Accumulated Other Comprehensive Income	0.00	0.00	-0.01	0.00	0.00
Additional Paid-in Capital	1.73	1.66	1.61	1.52	0.00
Shares Outstanding	0.01	0.01	0.01	0.01	0.00
Total Stockholders' Equity	0.38	0.65	0.83	0.93	0.72
Total Liabilities & Equity	0.49	0.75	0.94	1.13	0.00